Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes

NCT01295502 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT01295502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01295502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes
Lead sponsor
Gynecologic Oncology Group
Phase
Phase 1
Overall status
Unknown status
Start date
April 4, 2011
Completion date
Not reported
Enrollment
45 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenocarcinoma, cervical adenosquamous carcinoma, cervical squamous cell carcinoma, not otherwise specified, stage ib cervical cancer ajcc v6 and v7, stage iia cervical cancer ajcc v7, stage iib cervical cancer ajcc v6 and v7, stage iiia cervical cancer ajcc v6 and v7, stage iiib cervical cancer ajcc v6 and v7, stage iva cervical cancer ajcc v6 and v7